New Advancements in the Fight Against Appendix Cancer Using Breast Cancer Drug

Researchers at UC San Diego have found that palbociclib, a breast cancer drug, shows promise for treating a rare form of appendix cancer called peritoneal mucinous carcinomatosis (PMC).

Dr. Andrew Lowy, co-senior author and ACPMP Medical Advisory Board Member, says, “Finding that a breast cancer drug is successful in treating a subset of appendix cancer — where treatment options are currently limited — marks a significant advancement in our fight against this disease.”

This study, funded in part by the Appendix Cancer PMP Research Foundation, offers new hope for patients with this rare form of appendix cancer.

Read the full press release

Read the Study Published in the Journal of Clinical Oncology